Overview
BRNS market data
Price History
BRNS price chart · 3M
- O
- 0.719500
- H
- 0.719500
- L
- 0.719500
- C
- 0.719500
- Vol
- 2,300.00
- Source
- US equities market feed
- Observed
- Sep 3, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $0.72
- Previous Close
- $0.78
- Day High
- $0.72
- Day Low
- $0.72
- 52 Week High
- $0.79
- 52 Week Low
- $0.60
- 7 Day Return
- -4.07%
- 30 Day Return
- +19.94%
- 90 Day Return
- +5.70%
- 1 Year Return
- +7.39%
- Daily Notional Volume
- $1.7K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.64 Diluted earnings per share over the trailing twelve months.
- Beta
- -0.33 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -54.2% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.51 – $1.83 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $23.8M · P/B 0.37 · P/S 1.59.
Company News
2 captured
8-K filing — Barinthus Biotherapeutics plc. (BRNS)SEC EDGAR · Sep 1, 2026, 9:13 PM
Barinthus Biotherapeutics Q2 EPS $(0.26) Beats $(0.30) EstimateBenzinga · Aug 6, 2026, 12:42 PM